Hexarelin Acetate | Research Use Only

What it is

Hexarelin acetate, also known as examorelin acetate, is a synthetic growth hormone-releasing hexapeptide studied in research settings for its activity at the growth hormone secretagogue receptor. Reviews of the GHRP class describe Hexarelin as one of the better-known synthetic hexapeptide secretagogues developed for receptor and endocrine signaling research.

Origins and design rationale

Hexarelin was developed as part of the synthetic growth hormone secretagogue family to investigate non-GHRH pathways of GH release and receptor activation. Academic reviews describe GHRPs as synthetic peptides designed to stimulate growth hormone secretion through specific secretagogue receptors, with Hexarelin emerging as a later hexapeptide in this class alongside GHRP-2 and GHRP-6.

Molecular profile

Hexarelin is commonly described as a synthetic hexapeptide with the sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2. PubChem lists Hexarelin Acetate separately, and Cayman Chemical describes Hexarelin as a synthetic hexapeptide agonist of the growth hormone secretagogue receptor.

Scientific overview

In simplified terms, Hexarelin is used in research to study GHSR signaling, endocrine response patterns, and ghrelin-related receptor pharmacology. Published reviews also note that Hexarelin has been investigated in broader experimental systems, including cardiovascular and metabolic models, because of its interactions with GHSR and, in some contexts, CD36-related signaling.

What researchers study with Hexarelin Acetate

Key research focus areas often include
• Growth hormone secretagogue receptor signaling
• Endocrine and neuroendocrine response modeling
• Comparative studies of Hexarelin versus other synthetic GHRPs
• Cardiovascular and metabolic pathway research in experimental systems

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market Hexarelin Acetate for diagnosis, cure, mitigation, treatment, or prevention of disease.

Citations and references

PubChem compound entry for Hexarelin Acetate, includes compound identification and molecular information.

Imbimbo et al. Growth hormone-releasing activity of hexarelin in humans, describes Hexarelin as a new hexapeptide and reports its sequence.

Ghigo et al. Growth hormone-releasing peptides, review covering Hexarelin as a synthetic hexapeptide growth hormone secretagogue.

Camanni et al. Growth hormone-releasing peptides and their analogs, review summarizing the GHRP family and development rationale.

Mao et al. The cardiovascular action of hexarelin, review covering Hexarelin’s receptor biology and broader experimental research context.